|
WO2016074597A1
|
|
Crystal form of potassium-competitive acid blockers and preparation method therefor
|
|
CN105079816A
|
|
Tigecycline pharmaceutical composition and preparation method thereof
|
|
CN105106203A
|
|
Pharmaceutical composition with vonoprazan fumarate and preparation method thereof
|
|
CN105085311A
|
|
Efficient purification method of tigecycline or salt of tigecycline
|
|
WO2016019909A1
|
|
New crystal form of anticancer compound, preparation method and use thereof
|
|
WO2016019910A1
|
|
Crystal form of anticancer compound and preparation method and use thereof
|
|
CN105175467A
|
|
New crystal form of trifluridine, and preparation method thereof
|
|
CN104829541A
|
|
High selectivity and high purity method for preparing morinidazole
|
|
CN104844522A
|
|
Morinidazole crystal and preparation method and medical application thereof
|
|
CN104817536A
|
|
Medicinal imatinib mesylate non-acicular alpha crystal form and preparation method thereof
|
|
CN104761539A
|
|
Method for directionally preparing mesylate imatinib non-acicular alpha crystal form in high efficiency
|
|
CN104865321A
|
|
High sensitivity analysis and detection method of imatinib related substance
|
|
CN105037341A
|
|
Azilsartan alcohol ammonium crystal form and preparation method thereof
|
|
CN104945385A
|
|
Novel crystal form of Tipracil hydrochloride and preparation method thereof
|
|
CN104761605A
|
|
Recovery production process for decitabine mother liquor
|
|
CN104478854A
|
|
Preparation method of imatinib mesylate of non-acicular crystal form
|
|
CN104288115A
|
|
Medicinal preparation containing imatinib mesylate, and preparation method thereof
|
|
CN104510719A
|
|
Acotiamide tablet and preparation method thereof
|
|
CN105294547A
|
|
Method for removing palladium from perampanel crude product
|
|
CN104274410A
|
|
Pharmaceutical composition containing dabigatran etexilate or salt of dabigatran etexilate
|
